Efficacy of a Group Treatment Based on Transdiagnostic Perspective for Emotional Disorders and Applied in Blended Format: a Randomized Controlled Trial.

What this Trial Is About

Researchers are evaluating a group treatment based on a transdiagnostic approach to emotional disorders, comparing a blended format that combines face-to-face and online therapy with a traditional face-to-face group format. The study aims to assess the effectiveness, acceptability, retention, dropout rates, and adherence of both treatment methods. This randomized controlled trial will include adult participants diagnosed with various emotional disorders and will be conducted with ethical standards and informed consent. The study involves two treatment groups: one receiving the blended group transversal protocol (BLGr-TP) over 16 weeks, combining eight 2-hour face-to-face sessions with online self-applied modules accessed via a web platform; the other receiving the face-to-face group transversal protocol (FFGr-TP) with sixteen 2-hour face-to-face sessions and home tasks in paper format. Both treatments focus on psychoeducation, emotion regulation, exposure exercises, and relapse prevention. Participants will be evaluated at five points: before treatment, after treatment, and at 3, 6, and 12 months follow-up. Researchers will measure symptoms using scales for anxiety and depression severity, emotional regulation, quality of life, and other psychological and functional assessments. Weekly support messages will be sent during treatment to encourage adherence. The total participation duration spans up to 16 months, including follow-up assessments.

Efficacy of a Transdiagnostic Group Treatment for Emotional Disorders Applied in Blended Format: a Controlled Study.